APP and Alzheimer disease: Experimental ablation of pericytes leads to BBB breakdown, blood-flow reduction, white matter dysfunction and neuronal loss, while implantation of pericytes differentiated from C3H/10T1/2 mouse embryo fibroblasts in the brain cortex enhances cerebral blood flow and reduces Aβ pathology in APP/PS1 mouse model of AD [16, 17].